Deliver Your News to the World

CybeRelease: (OTC: GRGR) To Launch First Wood Biomass IPO


(CybeRelease, June 19, 2006) - Lake Harmony, PA - Green Energy Resources (OTC PK: GRGR) noted in today’s issue of Forbes Magazine, plans to launch the first wood biomass IPO on the London Aim Market.Wood cellulose is a potentially larger ingredient to ethanol and biodiesel fuel production than corn. Green Energy Resources has been working toward a London AIM listing since December of 2005. The company is an international supplier of wood biomass for clean coal technology, gasification, biofuels (ethanol and biodiesel) as well as direct burn energy to power plants. The company has access to over 30 million tons of wood, according to CEO, Joseph Murray and has recently hired a CFO to accelerate the timetable.

Alan Greenspan testifying before a US Senate Committee on June 7, stated corn based ethanol“ would only have a limited role” and“ its ability to replace gasoline is limited at best”. Greenspan said alternative biomass feedstocks such as wood, were ’’cheaper". A 2005 scientific breakthrough utilizing cellulostic fiber discovered at the College of Environmental Science in Syracuse, New York has thrust woodchips and woodfiber to the forefront of the ethanol production equation of the biofuels industry. President Bush in recent months has touted woodchips as a key to biofuels production in the United States.

For a Free Newsletter and more information, go to

To read the complete release, go to

CybeRelease Gainers are U.S. Energy Systems, Inc. (Nasdaq: USEY), FSI International, Inc. (Nasdaq: FSII), Align Technology, Inc. (Nasdaq: ALGN), Ceragon Networks Ltd. (Nasdaq: CRNT), OXiGENE, Inc. (Nasdaq: OXGN), Business Objects S.A. (Nasdaq: BOBJ), Sirius Satellite Radio Inc. (Nasdaq: SIRI) and Focus Media Holding Limited (Nasdaq: FMCN).

CybeRelease Decliners are Sangamo BioSciences, Inc. (Nasdaq: SGMO), China Medical Technologies, Inc. (Nasdaq: CMED), 1-800 Contacts, Inc. (Nasdaq: CTAC), Arch Capital Group Ltd. (Nasdaq: ACGL), DOV Pharmaceutical, Inc. (Nasdaq: DOVP), DXP Enterprises, Inc. (Nasdaq: DXPE), OmniVision Technologies, Inc. (Nasdaq: OVTI) and Finisar Corporation (Nasdaq: FNSR).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.